Core Laboratories N.V.
Core Laboratories N.V.（CLB）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · CLB · 截至 2026年6月9日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
0
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
Core Laboratories N.V.内部人在过去近12个月买卖活动混合。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
CLB 季度内部人买卖趋势
CLB 内幕交易卖出 · CLB 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
活跃内部人
近12个月交易最活跃 · CLB CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
CLB 高管卖出股份 · CLB 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| May 1, 2026 | Tattoli Mark Damian SVP, Gen Counsel & Secretary | Option | 250 | — | Form 4 |
| May 1, 2026 | Tattoli Mark Damian SVP, Gen Counsel & Secretary | Other | 97 | $1K | Form 4 |
| Apr 1, 2026 | Murray Katherine Director | Option | 8,069 | — | Form 4 |
| Apr 1, 2026 | ANASTASIO CURT Director | Option | 8,069 | — | Form 4 |
| Apr 1, 2026 | Klingensmith Harvey Robert Director | Option | 8,069 | — | Form 4 |
| Apr 1, 2026 | Temeng Kwaku Director | Option | 8,069 | — | Form 4 |
| Apr 1, 2026 | MARTINOVICH ROBERT F Director | Option | 8,069 | — | Form 4 |
| Apr 1, 2026 | Carnes Martha Z. Director | Option | 8,069 | — | Form 4 |
| Dec 31, 2025 | Tattoli Mark Damian SVP, Gen Counsel & Secretary | Option | 24,952 | — | Form 4 |
| Dec 31, 2025 | Tattoli Mark Damian SVP, Gen Counsel & Secretary | Other | 14,310 | $229K | Form 4 |
| Dec 31, 2025 | Gresham Gwendolyn SVP | Option | 24,952 | — | Form 4 |
| Dec 31, 2025 | Gresham Gwendolyn SVP | Other | 19,301 | $309K | Form 4 |
| Dec 31, 2025 | Hill Christopher Scott SVP & CFO | Option | 61,417 | — | Form 4 |
| Dec 31, 2025 | Hill Christopher Scott SVP & CFO | Other | 32,152 | $515K | Form 4 |
| Dec 31, 2025 | Bruno Lawrence Chairman and CEO · Director | Option | 180,722 | — | Form 4 |
| Dec 31, 2025 | Bruno Lawrence Chairman and CEO · Director | Other | 112,681 | $1.81M⚡ | Form 4 |
| Dec 1, 2025 | Teo Sow Hang CAO & Treasurer | Option | 864 | — | Form 4 |
| Dec 1, 2025 | Teo Sow Hang CAO & Treasurer | Other | 340 | $5K | Form 4 |
| Oct 1, 2025 | Tattoli Mark Damian SVP, Gen Counsel & Secretary | Option | 700 | — | Form 4 |
| Oct 1, 2025 | Tattoli Mark Damian SVP, Gen Counsel & Secretary | Other | 276 | $3K | Form 4 |
| Oct 1, 2025 | Teo Sow Hang CAO & Treasurer | Option | 250 | — | Form 4 |
| Oct 1, 2025 | Teo Sow Hang CAO & Treasurer | Other | 99 | $1K | Form 4 |
| Aug 1, 2025 | Tattoli Mark Damian SVP, Gen Counsel & Secretary | Option | 250 | — | Form 4 |
| Aug 1, 2025 | Tattoli Mark Damian SVP, Gen Counsel & Secretary | Other | 99 | $1K | Form 4 |
| Aug 1, 2025 | Teo Sow Hang CAO & Treasurer | Option | 200 | — | Form 4 |
Tattoli Mark Damian
SVP, Gen Counsel & Secretary
日期
Dec 31
股数
14,310
均价
$16.03
总金额
$229K
Bruno Lawrence
Chairman and CEO · Director
日期
Dec 31
股数
112,681
均价
$16.03
总金额
$1.81M ⚡
Tattoli Mark Damian
SVP, Gen Counsel & Secretary
日期
Oct 1
股数
276
均价
$12.58
总金额
$3K
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 CLB 内幕交易
CLB 内幕交易
Core Laboratories N.V.（CLB）内幕交易数据来源于公司内部人（包括Tattoli Mark Damian (SVP, Gen Counsel & Secretary), Teo Sow Hang (CAO & Treasurer), Gresham Gwendolyn (SVP)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。CLB内部人近期买卖活动混合，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Core Laboratories N.V.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
CLB 内幕交易 · 5个问题Core Laboratories N.V.（CLB）的内部人包括高管和董事，如Tattoli Mark Damian (SVP, Gen Counsel & Secretary), Teo Sow Hang (CAO & Treasurer), Gresham Gwendolyn (SVP)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026